Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, May 2008, p. 1868-1870, Vol. 52, No. 5
0066-4804/08/$08.00+0 doi:10.1128/AAC.01369-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Department of Molecular Microbiology and Immunology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan,1 Department of Bioactive Molecules, National Institute of Infectious Disease, Tokyo, Japan,2 Kaken Pharmaceutical Co., Ltd., Kyoto, Japan3
Received 24 October 2007/ Returned for modification 20 November 2007/ Accepted 16 February 2008
SPK-843, a new polyene antifungal, exhibited dose-dependent efficacy on murine pulmonary aspergillosis models. SPK-843 doses of higher than 1.0 mg/kg of body weight exhibited no renal toxicities and a tendency toward better survival prolongation than the estimated maximum tolerated doses of amphotericin B (Fungizone) (1.0 mg/kg) and liposomal amphotericin B (AmBisome) (8.0 mg/kg).
Published ahead of print on 25 February 2008.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»